Blood Pressure Management Ameliorates the Severity of Neurological Events

The ENDURANCE Supplemental trial was designed to assess the effectiveness of an enhanced blood pressure (BP) management protocol in reducing the occurrence of neurological events in patients ineligible for cardiac transplantation receiving the Medtronic HeartWareTM HVADTM System. The trial demonstrated that enhanced BP management significantly reduced the mean arterial pressure (MAP) and the incidence of hemorrhagic strokes compared to the original ENDURANCE trial. This subsequent analysis sought to understand the effects of BP management on stroke severity and recovery.

Source: The Journal of Heart and Lung Transplantation - March 31, 2018 Category: Transplant Surgery Authors: J.J. Teuteberg, J.G. Rogers, C.A. Milano, M.S. Kiernan, G.S. Couper, S.W. Boyce, C. Mahr, N.A. Mokadam, T.A. Vassiliades, F.D. Pagani Source Type: research